Peer Reviewed
Case studies

A patient with familial hypercholesterolaemia unable to achieve target LDL-cholesterol levels

Leon A Simons
Abstract
Without treatment, a man with heterozygous familial hypercholesterolaemia has a 51% chance of presenting with coronary disease by age 50 years and a woman has a 58% chance by age 60 years.
Key Points
  • Patients with heterozygous familial hypercholesterolaemia (FH) have a high risk of manifesting with premature coronary disease.
  • Treatment with statins (and other standard cardiovascular medications) is likely to be beneficial.
  • Multiple lipid-regulating drugs may not achieve target LDL-cholesterol readings in patients with FH, but a 50% reduction in LDL-cholesterol levels is acknowledged as an acceptable secondary goal.
Purchase the PDF version of this article
Purchase PDF AUD$34.99
Subscribe for full access to all articles
Already a subscriber?